Humacyte earnings report
WebDURHAM, N.C., March 21, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally … Web12 nov. 2024 · Humacyte, Inc. Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) (in thousands, except share and per share amounts) …
Humacyte earnings report
Did you know?
Web11 apr. 2024 · The MarketWatch News Department was not involved in the creation of this content. DURHAM, Apr 11, 2024 (GLOBE NEWSWIRE via COMTEX) -- DURHAM, N.C., … Web13 apr. 2024 · Detailed statistics for Humacyte, Inc. (HUMA) stock, including valuation metrics, financial numbers, share information and more. Skip to main content. Log In Free Trial. Home. Stocks. ... The next earnings date is Friday, May 12, 2024, before market open. Estimated Earnings Date May 12, 2024: Ex-Dividend Date n/a: Share ...
Web12 apr. 2024 · Humacyte (HUMA Quick Quote HUMA - Free Report) rose almost 13% on Apr 11, post the completion of patient enrollment in the phase III, V007 clinical study on the human acellular vessel (HAV) product. WebHUMA Earnings Forecast Next quarter’s earnings estimate for HUMA is -$0.21 with a range of -$0.22 to -$0.20. The previous quarter’s EPS was -$0.04. HUMA beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 54.35% of the time in the same period.
Web10 nov. 2024 · Third Quarter 2024 Financial Highlights. The Company reported cash, cash equivalents and short-term investments of $171.7 million as of September 30, 2024, compared to $225.5 million as of December 31, 2024. The $53.8 million net use of cash, cash equivalents and short-term investments for the first nine months of 2024 resulted … Web24 mrt. 2024 · Humacyte, Inc. (HUMA) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate of a loss of $0.24. This compares to loss of $0.22 …
Web10 uur geleden · Humacyte, Inc.'s consensus EPS estimate for the upcoming report has changed +16.3% over the past month to -$0.22. Compared to the company's year-ago EPS, this represents no change. Humacyte, Inc ...
Web12 apr. 2024 · Humacyte HUMA rose almost ... here.Loss per share estimates for CRISPR have narrowed from $8.21 to $7.35 for 2024 in the past 60 days.The company's … mid century bathroom rugsWeb13 apr. 2024 · Humacyte, Inc. (HUMA) latest earnings report: revenue, EPS, surprise, history, news and analysis. Seeking Alpha - Go to Homepage Entering text into the input … mid century bathroom vanitiesWeb22 mrt. 2024 · Humacyte (NASDAQ:HUMA - Get Rating) will post its quarterly earnings results before the market opens on Friday, March 24th.Analysts expect Humacyte to … mid century bedroom suiteWebFind the latest Earnings Report Date for Humacyte, Inc. Warrant (HUMAW) at Nasdaq.com. mid century bath vanitiesWeb23 mrt. 2024 · Wall Street analysts expect Humacyte will report losses per share of $0.235. Follow Humacyte stock price in real-time here. On March 24, Humacyte will release … mid century benchWeb24 mrt. 2024 · Investing.com - Humacyte (NASDAQ: HUMA) reported fourth quarter EPS of $-0.04, $0.19 better than the analyst estimate of $-0.23. Revenue for the quarter came in at $5K versus the consensus... mid century bench sofaWebThe 6 analysts offering 12-month price forecasts for Humacyte Inc have a median target of 7.00, with a high estimate of 20.00 and a low estimate of 2.75. The median estimate represents a +160.22%... news of the world editor